Bigi Soft Drinks might Induce Hyperglycemia and Hyperlipidemia in Wistar Rats

Main Article Content

Augustine I. Airaodion
Emmanuel O. Ogbuagu
John A. Ekenjoku
Victor N. Okoroukwu
Uloaku Ogbuagu


Background: Bigi soft drinks are carbonated drinks produced by Rite Foods Limited. The company is an indigenous company in Nigeria. Before 2016, Coca-cola bottling company and 7up bottling company products were the dominant soft drinks in Nigeria. Rite Foods Limited introduced carbonated soft drinks into the Nigerian market in 2016 and have favourably competed with the existing products. As at today, Bigi soft drinks are the dominant soft drinks in Nigeria because of their palatable taste, large volume and low price.

Aim: This study sought to investigate the effect of Bigi soft drinks on fasting blood glucose and lipid profile of Wistar rats.

Methods: Thirty-five adult Wistar rats were used for this study. They were randomly divided into seven groups of five rats each after seven days acclimatization. They were treated accordingly: animals in group 1 were administered distilled water, those in group 2 were administered Bigi Cola, those in group 3 were administered Bigi Apple, those in group 4 were administered Bigi Tropical, those in group 5 were administered Bigi Orange, those in group 6 were administered Bigi Lemon and Lime, while those in group 7 were administered Bigi Chapman. The administration was done orally at a dose of 3 mL per 100 g body weight 12 hourly for fourteen days. At the end of the administration period, the animals were fasted overnight and anaesthetized using diethyl ether. Blood samples were collected by cardiac puncture. Fasting blood glucose and lipid profile were determined using standard methods.

Results: All the soft drinks used in this study (except Bigi Lemon and Lime) significantly increased the fasting blood glucose of animals. All the Bigi soft drinks (except Bigi Cola) significantly increased triglyceride, total cholesterol and VLDL of animals when compared with control at p<0.05 respectively. The soft drinks also perturbed the HDL and LDL of animals used in this study.

Conclusion: The result of this study implies that Bigi soft drinks might be deleterious to health as far as hyperglycemia and hyperlipidaemia is concern. This does not automatically translate to such effect on humans. However, individuals with a diabetic family history should minimize their consumption of these drinks.

Bigi soft drinks, fasting blood glucose, lipid profile, diabetes, cardiovascular diseases.

Article Details

How to Cite
Airaodion, A. I., O. Ogbuagu, E., A. Ekenjoku, J., N. Okoroukwu, V., & Ogbuagu, U. (2019). Bigi Soft Drinks might Induce Hyperglycemia and Hyperlipidemia in Wistar Rats. International Journal of Research and Reports in Hematology, 2(4), 1-10. Retrieved from
Original Research Article


Vartanian LR, Schwartz MB, Brownell KD. Effects of soft drink consumption on nutrition and health: A systematic review and meta-analysis. American Journal of Public Health. 2007;97(4):667–675.

Ebbeling CB, Feldman HA, Osganian SK, Chomitz VR, Ellenbogen SJ, Ludwig DS. Effects of decreasing sugar-sweetened beverage consumption on body weight in adolescents: A randomized, controlled pilot study. Pediatrics. 2006;117(3):673– 680.

Malik VS, Schulze MB, Hu FB. Intake of sugar sweetened beverages and weight gain: A systematic review. American Journal of Clinical Nutrition. 2006;84(2): 274–328.

Wolff E, Dangsinger ML. Soft drinks and weight gain: How strong is the link? Medscape Journal of Medicine. 2008;10 (8):189.

Caroline DW. Type 1 diabetes mellitus in pediatrics. Pediatr Rev. 2008;29 (11):374–384.

Gibson S. Sugar-sweetened soft drinks and obesity: A systematic review of the evidence from observational studies and interventions. Nutrition Research Reviews. 2008;21(2):134–147.

Ludwig D, Peterson K, Gortmaker S. Relation between consumption of sugar-sweetened drinks and childhood obesity: A prospective, observational analysis. The Lancet. 2001;357(9255):505–508.

Schulze MB, Manson JAE, Ludwig DS, Colditz GA, Stampfer MJ, Willet WC, Hu FB. Sugar sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle aged women. Journal of the American Medical Association. 2004; 292(8):927–934.

Dubois HFW, Bankauskaite V. Type 2 diabetes programmes in Europe. Euro Observer. 2005;7(2):5–6.

Ashurst P. Soft drink and fruit juice problems solved. Woodhead Publishing Limited; 2009.

ISBN 978-1-84569- 326-328

Raben A, Vasilaras TH, Moller AC, Astrup A. Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 weeks of supplementation in overweight subjects. American Journal of Clinical Nutrition. 2002;76(4):721–729.

Nielsen S, Popkin B. Changes in beverage intake between 1977 and 2001. American Journal of Preventive Medicine. 2009; 27(3):205–210.

Ripsin CM, Kang H, Urban RJ. Management of blood glucose in type 2 diabetes mellitus. American Family Physician. 2009;79(1):29–36.

Konstantinos L. Aretaeus of Cappadocia and the first description of diabetes". Hormones. 2012;11(1):109–113.

Ripoll BC, Leutholtz I. Exercise and disease management (2nd Ed.). Boca Raton: CRC Press. 2011;25.

ISBN 978-1-4398-2759-8

Santaguida PL, Balion C, Hunt D. Diagnosis, prognosis, treatment of impaired glucose tolerance and impaired fasting glucose. Evid Rep Technol Assess. 2008;12:1–11.

Trocho C, Pardo RT. Formaldehyde derived from dietary aspartame binds to tissue components in vivo. Life Sci: 1998; 637-349.

Lambert P, Bingley PJ. What is type 1 diabetes? Medicine. 2002;30:1–5.

Rother KI. Diabetes treatment—bridging the divide. The New England Journal of Medicine. 2007;356(15):1499–501.

Stewart WF, Ricci JA, Chee E, Hirsch AG, Brandenburg NA. Lost productive time and costs due to diabetes and diabetic neuropathic pain in the US workforce. J. Occup. Environ. Med. 2007;49(6):672–679.

Shoback DG, Gardner D. Eds. Chapter 17". Greenspan's Basic & Clinical Endocrinology (9th Ed.). New York: McGraw-Hill Medical; 2011.

ISBN: 978-0-07-162243-1

Saydah SH, Miret M, Sung J, Varas C, Gause D, Brancati FL. Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care. 2001;24(8):1397–1402.

Dorner M, Pinget M, Brogard JM. Essential labile diabetes (in German). Munch Med Wochenschr. 1977;119(19):671–674.

Jaiprakash J, Thomas P, Cavan D, Kerr D. "Preventing childhood obesity by reducing consumption of carbonated drinks: Cluster randomized controlled trial. British Medical Journal. 1993;328(7450):1237.

Vijan S. "Type 2 diabetes". Annals of Internal Medicine. 2010;152(5):ITC31-15.

Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N. Engl. J. Med. 2010; 362(9):800–811

Airaodion AI, Airaodion EO, Ogbuagu EO, Ogbuagu U, Osemwowa EU. Effect of Oral Intake of African Locust Bean on Fasting Blood Sugar and Lipid Profile of Albino Rats. Asian Journal of Research in Biochemistry. 2019;4(4):1-9.

Owoade AO, Adetutu A, Airaodion AI, Ogundipe OO. Toxicological assessment of the methanolic leaf extract of Bridelia ferrugelia. The Journal of Phytopharmacology. 2018;7(5):419-424.

Owoade AO, Airaodion AI, Adetutu A, Akinyomi OD. Levofloxacin-induced dyslipidemia in male albino rats. Asian Journal of Pharmacy and Pharmacology. 2018;4(5):620-629.

Airaodion AI, Ogbuagu EO, Airaodion EO, Ekenjoku JA, Ogbuagu U. Pharmacotherapeutic effect of methanolic extract of Telfairia occidentalis leaves on glycemic and lipidemic indexes of alloxan-induced diabetic rats. International Journal of Bio-Science and Bio-Technology. 2019;11(8):1-17.

Bahadoran Z, Golzarand M, Mirmiran P, Saadati N, Azizi F. The association of dietary phytochemical index and cardio-metabolic risk factors inadults: Tehran lipid and glucose study. Journal of Human Nutrition and Diet. In print; 2013.

Airaodion AI, Olatoyinbo PO, Ogbuagu U, Ogbuagu EO, Akinmolayan JD, Adekale OA, Awosanya OO, Oloruntoba AP, Agunbiade AP, Airaodion EO, Adeniji AR, Obajimi OO. Comparative assessment of phytochemical content and antioxidant potential of Azadirachta indica and Parquetina nigrescens leaves. Asian Plant Research Journal. 2019;2(3):1-14.

Airaodion AI, Ibrahim AH, Ogbuagu U, Ogbuagu EO, Awosanya OO, Akinmolayan JD, Njoku OC, Obajimi OO, Adeniji AR, Adekale OA. Evaluation of Phytochemical Content and Antioxidant Potential of Ocimum gratissimum and Telfairia occidentalis Leaves. Asian Journal of Research in Medical and Pharmaceutical Sciences. 2019;7(1):1-11.

Airaodion AI, Akinmolayan JD, Ogbuagu EO, Airaodion EO, Ogbuagu U, Awosanya OO. Effect of methanolic extract of Corchorus olitorius Leaves on hypoglycemic and hypolipidaemic activities in albino rats. Asian Plant Research Journal. 2019;2(7):1-13

Loci AS, Shaabha M, Khazraji AL, Husain A, Twaija A. Hypoglycemic effect of a valuable extract on some blood parameters in diabetic animals. J. Ethnopharmacol. 1994;43:167–171.

Ahardh CD, Bjorgell P, Nilson EP. The effect of tolnetamide in lipoproteins and lipoprotein lipase and hormone sensitive lipase. Diabetes Res. Clin. Pract. 1999;46: 99–108.

Frayn KN. Insulin resistance and lipid metabolism. Curr. Opin. Lipidol. 1993;4: 197–204.

Bopanna KN, Kannan J, Suchma G, Balaraman R, Ranthod SP. Antidiabetic and antihyperlipidemic effect of neem seed, kernel powder on alloxan diabetic rabbits. Ind. J. Pharmacol. 1997;29:162–167.

Rotimi OS, David AO, Olusola AT, Regina NU, Elizabeth AB, Oladipo A. Amoxillinand pefloxacin-induced cholesterogenesis and phospholipidosis in rat tissues. Lipids in Health and Disease. 2015;14:13-30.

Airaodion AI, Ogbuagu EO, Ekenjoku JA, Ogbuagu U. Antidiabetic effect of ethanolic extract of Carica papaya leaves in alloxan-induced diabetic rats. American Journal of Biomedical Science & Research. 2019; 5(3):227-234

Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacological Research. 2005;52:313–320.

Balamurugan R, Ignacimuthu S. Antidiabetic and Hypolipidemic effect of methanol extract of Lippia nodifloral. In streptozotocin induced diabetic rats. Asia Pacific Journal of Tropical Biomedicine. 2011;S30-S36.

Allen RR, Carson LA, Kwik-Uribe C, Evans E, Erdman JW. Daily consumption of a dark chocolate containing flavanols and added sterol esters affects cardiovascular risk factors in normotensive population with elevated cholesterol. J Nutr. 2008;138: 725-731.

Greene CM, Zern TL, Wood RJ, Shrestha S, Fernandez ML. Maintenance of the LDL-cholesterol/ HDL-cholesterol ratio in an elderly population given a dietary cholesterol challenge. J Nutr. 2005;135: 2793-2798.

Perona JS, Covas MI, Fito M, Cabello-Moruno R, Aros F, Corella D, Ros E, Garcia M, Estruch R, Martinez-Gonzalez MA, Ruiz-Gutierrez V. Reduction in systemic and VLDL triacylglycerol concentration after a 3-month Mediterranean style diet in high-cardiovascular-risk subjects. J Nutr Biochem. 2010;9:892-898.

Gordon DJ, Rifkind BM. High-density lipoprotein: The clinical implications of recent studies. New England Journal of Medicine. 1989;321(19):1311-1316.

Sviridiv D. Intracellular cholesterol trafficking. Histology and Histopathology. 1999;14:305-319.

Airaodion AI, Adeniji AR, Ogbuagu EO, Ogbuagu U, Agunbiade AP. Hypoglycemic and hypolipidaemic activities of methanolic extract of Talinum triangulare leaves in Wistar rats. International Journal of Bio-Science and Bio-Technology. 2019;11(5): 1-13

Oram JF, Lawn RM. ABCA1: The gatekeeper for eliminating excess tissue cholesterol. Journal Lipid Research. 2001;42:1173-1179.

Law MR. Lowering heart disease risk with cholesterol reduction: Evidence from observational studies and clinical trials. European Heart Journal. 1999;1:S3-S8.

Stein O, Stein Y. Atheroprotective mechanisms of HDL- Atherosclerosis. 1999;144:285-303.

Ogbuagu EO, Airaodion AI, Ogbuagu U, Airaodion EO. Effect of methanolic extract of Vernonia amygdalina leaves on glycemic and lipidaemic indexes of Wistar rats. Asian Journal of Research in Medical and Pharmaceutical Sciences. 2019;7(3): 1-14.

Cromwell WC, Otvos JD. Low Density Lipoprotein Particle Number and Risk for Cardiovascular Disease. Curr. Atheroscler. Rep. 2004;6(8):381-387.

Castelli L. Epidemiology of coronary heart disease. Am. J. Med. 1984;76:4–12.